RG

Rekha Girish Janganure

Active Director Director DIN 09371138
DIN 09371138 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rekha Girish Janganure

Data last updated:

Rekha Girish Janganure is a Director at Genrise Medicine Private Limited (since 2021). The company operates in Chemicals.

DIN 09371138
Primary Designation Director
Industry Chemicals
First Appointment 22 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genrise Medicine Private Limited U24299KA2021PTC153415
Director22 Oct 20212021Active

Board colleagues of Rekha Girish Janganure

NameDINCompanyDesignation
Girish Subhash Jagnure08631614Genrise Medicine Private LimitedDirector

Directorship timeline

Open interactive timeline →
Genrise Medicine Private Limited
Premium access

Shareholding and investment profile for Rekha Girish Janganure

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Girish Janganure

Rekha Girish Janganure currently holds 1 directorship: Genrise Medicine Private Limited (Director, since 22 Oct 2021).

Rekha Girish Janganure was first appointed on 22 Oct 2021 as Director at Genrise Medicine Private Limited.

The current boards of Rekha Girish Janganure's companies include Girish Subhash Jagnure (Genrise Medicine Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available